- Home
- SUPN vs LKFN Comparison
SUPN vs LKFN Comparison
Compare SUPN & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- LKFN
- Stock Information
- Founded
- SUPN 2005
- LKFN 1872
- Country
- SUPN United States
- LKFN United States
- Employees
- SUPN N/A
- LKFN N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- LKFN Major Banks
- Sector
- SUPN Health Care
- LKFN Finance
- Exchange
- SUPN Nasdaq
- LKFN Nasdaq
- Market Cap
- SUPN 1.9B
- LKFN 1.6B
- IPO Year
- SUPN 2012
- LKFN 1997
- Fundamental
- Price
- SUPN $33.56
- LKFN $65.40
- Analyst Decision
- SUPN Hold
- LKFN Buy
- Analyst Count
- SUPN 2
- LKFN 2
- Target Price
- SUPN $36.00
- LKFN $68.00
- AVG Volume (30 Days)
- SUPN 681.6K
- LKFN 208.2K
- Earning Date
- SUPN 08-05-2025
- LKFN 07-25-2025
- Dividend Yield
- SUPN N/A
- LKFN 3.02%
- EPS Growth
- SUPN N/A
- LKFN N/A
- EPS
- SUPN 1.11
- LKFN 3.67
- Revenue
- SUPN $667,997,000.00
- LKFN $238,375,000.00
- Revenue This Year
- SUPN N/A
- LKFN $16.03
- Revenue Next Year
- SUPN $15.74
- LKFN $4.31
- P/E Ratio
- SUPN $30.78
- LKFN $18.04
- Revenue Growth
- SUPN 11.82
- LKFN N/A
- 52 Week Low
- SUPN $27.05
- LKFN $50.00
- 52 Week High
- SUPN $40.28
- LKFN $78.61
- Technical
- Relative Strength Index (RSI)
- SUPN 57.11
- LKFN 55.32
- Support Level
- SUPN $32.94
- LKFN $63.54
- Resistance Level
- SUPN $34.21
- LKFN $68.79
- Average True Range (ATR)
- SUPN 1.06
- LKFN 1.65
- MACD
- SUPN 0.04
- LKFN -0.08
- Stochastic Oscillator
- SUPN 56.90
- LKFN 37.68
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About LKFN Lakeland Financial Corporation
Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.